Hostname: page-component-7bb8b95d7b-fmk2r Total loading time: 0 Render date: 2024-09-20T15:35:57.846Z Has data issue: false hasContentIssue false
  • English
  • Français

Proliferating cell nuclear antigen in laryngeal cancer

Published online by Cambridge University Press:  29 June 2007

Tomasz Kręcicki  and
Michal Jeleń
Tomasz Kręcicki*
Affiliation:
Department and Clinic of Otolaryngology, Medical University of Wroclaw, Poland.
Michal Jeleń
Affiliation:
Department of Pathology, Medical University of Wroclaw, Poland.
*
Address for correspondence: Tomasz Krecicki, M. D., ul.Smolenskiego 4, 51–607 Wroclaw, Poland. Fax: 0-48713285415
Get access Rights & Permissions [Opens in a new window]

Abstract

The expression of proliferating cell nuclear antigen in paraffin sections from 154 cases of laryngeal squamous cell carcinoma were examined. There was significant difference in PCNA expression between the control group and cancer patients (p<0.001). The mean score of PCNA was higher in patients with poor prognosis than in patients with satisfactory outcome after treatment (p<0.05). There was no significant correlation between the PCNA count and the patient's age and sex, T and N stage and site of the tumour.

Univariate analysis revealed that the PCNA score correlated with the patients' survival rates. In multivariate analysis the prognostic value of PCNA was on the statistical borderline (p = 0.049). In our study clinical features like N and T status had a more important influence on survival rate. Nevertheless it appears that the immunohistological examination of PCNA in paraffin section could be a complementary prognostic tool for laryngeal carcinoma. PCNA expression may also be a valuable tool for differentiating malignant from benign laryngeal epithelium.

Keywords

Laryngeal neoplasmsProliferating cell nuclear antigen (PCNA)
Type
Pathology in Focus
Information
The Journal of Laryngology & Otology , Volume 112 , Issue 3 , March 1998 , pp. 310 - 313
Copyright
Copyright © JLO (1984) Limited 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aaltomaa, S., Lipponen, P. M., Syrjanen, K. (1992) Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining. Anticancer Research 12: 1281–1286.Google ScholarPubMed
Dawson, A. E., Norton, J. A., Weinberg, D. S. (1990) Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. American Journal of Pathology 136: 1115–1124.Google ScholarPubMed
Fontanini, G., Macchiarini, P., Pepe, S., Ruggiero, A., Hardin, M., Bigini, D., Vignati, S., Pingitare, R., Angeletti, C. A. (1992) The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer 70: 1520–1527.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Frankenthaler, R. A., El-Naggar, A. K., Ordonez, N. G., Miller, T. S., Batsakis, J. G. (1994) High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland. Otolaryngology – Head and Neck Surgery 111: 460–466.CrossRefGoogle ScholarPubMed
Golusiński, W., Szmeja, Z., Olofsson, J., Biczysko, W., Krygier-Stojalowska, A., Majewski, P. (1996) Wartosc diagnostyczna i prognostyczna onkogenu p53 wybranych markerów nowotworowych (Ki67, PCNA, DNA ploidii) ultrastruktury u chorych na raka krtani. Otolaryngologia Polska 50: 607–617.Google Scholar
Hall, P. A., Levison, D. A., Woods, A. L., Yu, C. C., Kellock, D. B., Watkins, J. A., Barnes, D. M., Gillett, C. E., Camplejohn, R., Dover, R., Waseem, N. H., Lane, D. P. (1990) Proliferating cell nuclear antigen (PCNA) immuno-localization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. Journal of Pathology 162: 285–294.CrossRefGoogle Scholar
Harper, M. E., Glynne-Jones, E., Goddard, L., Wilson, D. W., Metenhelia, S. S., Conn, I. G., Peeling, W. B., Griffiths, K. (1992) Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate 20: 243–253.CrossRefGoogle ScholarPubMed
Jain, S., Filipe, M. I., Hall, P. A., Wassem, N. H., Lane, D. P., Levison, D. A. (1991) Prognostic value of proliferating cell nuclear antigen in gastric cancer. Journal of Clinical Pathology 44: 655–659.CrossRefGoogle Scholar
Kram, A., DomagaJa, W. (1996) Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous carcinomas. An immunohistochemical study. Polish Journal of Pathology 47: 183–187.Google ScholarPubMed
Lam, K., Law, S., So, M., Ma, L., Wong, J. (1996) Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer 77: 7–13.3.0.CO;2-N>CrossRefGoogle ScholarPubMed
Lipponen, P. K., Eskelinen, M. J. (1992) Cell proliferation of transitional cell bladder tumours determined by PCNA/ cyclin immunostaining and its prognostic value. British Journal of Cancer 66: 171–176.CrossRefGoogle ScholarPubMed
Lorz, M., Meyer-Breiting, E., Bettinger, R. (1994) Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer. European Archives of Otorhinolaryngology 251: 91–94.CrossRefGoogle ScholarPubMed
Miyachi, K., Fritzler, M. J., Tan, E. M. (1978) Autoantibody to a nuclear antigen in proliferating cells. Journal of Immunology 121: 2228–2234.CrossRefGoogle ScholarPubMed
Munck-Wikland, E., Edstroem, S., Jungmark, E., Kuylen-stierna, R., Lindholm, J., Auer, G. (1994) Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. International Journal of Cancer 56: 95–99.CrossRefGoogle ScholarPubMed
Pich, A., Chiusa, L., Pisani, P., Krengli, M., Pia, F., Novone, R. (1992) Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology 119: 106–110.CrossRefGoogle ScholarPubMed
Roland, N. J., Caslin, A. W., Bowie, G. L., Jones, A. S. (1994) Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clinical Otolaryngology 19: 13–18.CrossRefGoogle ScholarPubMed
Shin, D. M., Voravud, N., Ro, J. Y., Lee, J. S., Hong, W. K., Hittelman, W. N. (1993) Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. Journal of the National Cancer Institute 85: 971–978.CrossRefGoogle ScholarPubMed
Skopelitou, A., Korkolopoulou, P., Papanikolau, A., Had-jiyannakis, M. (1993) Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma. Journal of Cancer Research and Clinical Oncology 119: 379–381.CrossRefGoogle ScholarPubMed
Störkel, S., Reichert, T., Reiffen, K. A., Wagner, W. (1993) EGFR and PCNA expression in oral squamous cell carcinomas – a valuable tool in estimating the patient's prognosis. European Journal of Cancer 29B: 273–277.CrossRefGoogle ScholarPubMed
Tomasino, R. M., Daniele, E., Bazan, V., Morello, V., Tralongo, V., Nuara, R., Nagar, C., Salvato, M., Ingria, F., Restivo, S. (1995) Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Research 55: 6103–6108.Google ScholarPubMed
Tsuji, T., Shrestha, P., Yamada, K., Takagi, H., Shinozaki, F., Sasaki, K., Maeda, K., Mori, M. (1992) Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study. Virchows Archives A, Pathological Anatomy and Histopathology 420: 377–383.CrossRefGoogle ScholarPubMed
Welkoborsky, H. J., Hinni, M., Dienes, H. P., Mann, W. J. (1995) Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumour front grading, and proliferation markers. Annals of Otology, Rhinology and Laryngology 104: 503–510.CrossRefGoogle ScholarPubMed
Wen, Q. H., Nishimura, T., Miwa, T., Nagayama, I., Furukawa, M. (1995) Expression of EGF, EGFR and PCNA in laryngeal lesions. Journal of Laryngology and Otology 109: 630–636.CrossRefGoogle ScholarPubMed
Woods, A. L., Hall, P. A., Shepherd, N. A., Hanby, A. M., Waseem, N. H., Lane, D. P., Levison, D. A. (1991) The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 18: 21–27.CrossRefGoogle Scholar
Yang, L., Hashimura, K., Qin, C., Shrestha, P., Sumitomo, S., Mori, M. (1993) Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential. Virchows Archives A, Pathological Anatomy and Histopathology 422: 481–486.CrossRefGoogle ScholarPubMed